Synta to Present at Upcoming September Investor Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)-- Synta Pharmaceuticals Corp. (SNTA) today announced that the Company will present at the following September investor conferences:
& Renshaw Annual Global Investment Conference
in New York
Monday, September 10 at 1:35 p.m. (ET)
9th Annual Growth Conference in New York
Wednesday, September 12 at 3:30 p.m. (ET)
Global Life Sciences Conference
in New York
Thursday, September 20, 2012 at 3:30 p.m. (ET)
Noble Financial Markets Life Sciences Exposition
in Stamford, CT
Monday, September 24, 2012 at 1:00 p.m. (ET)
Live audio webcasts and replays of these presentations will be available on the "Investors" section of the Company's website, www.syntapharma.com.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7125
Source: Synta Pharmaceuticals Corp.Copyright Business Wire 2012